Hematopoietic Stem Cell Transplantation (HSCT) Market-Opportunity Analysis, 2017 - 2025
Rising incidence of leukemia and lymphoma and continuous research on hematopoietic stem cells are expected to drive market growth
As per 2017 report by Leukemia and Lymphoma Society, the U.S. alone is expected to account for a prevalence of 8,16,834 and incidence of 80,500 for lymphoma. Increasing rate of incidence is in turn, expected to increase the demand for hematopoietic stem cell transplantation thus, propelling growth of the hematopoietic stem cell transplantation (HSCT) market. Increasing awareness about stem cell therapies among the population is also expected to propel growth of the hematopoietic stem cell transplantation market. As per survey by World Network for Blood and Marrow Transplantation (WBMN), around one million hematopoietic stem cell transplantation procedures were performed during 2006 to 2014, which indicates potential opportunities for market players.
However, high costs associated with hematopoietic stem cell transplantation procedures are expected to hinder growth of the market. Other factors such as difficulty in finding a donor for allogeneic transplantation, technological barriers (currently used culture technologies, point of care delivery, and lack of analytical assay), and side effects such as graft vs. host disease, are also expected to slow down growth of the hematopoietic stem cell transplantation market.
Request For Sample Copy@
Global Hematopoietic Stem Cell Transplantation Market Taxonomy
On the basis of indication:
Other non-malignant disorders (thalassemia, sickle cell anemia, Osteoporosis, Immunodeficiency syndrome)
On the basis of application:
Peripheral blood cells
Umbilical cord blood
Increasing adoption of the growing trend of personalized medicine is expected to drive growth of the hematopoietic stem cells transplantation market. A collaborative research study on hematopoietic stem cell transplantation initiated by World Network for Blood and Marrow Transplantation (WBMN) in 2013 in the domain of promotion of access to hematopoietic stem cell transplantation, developed a donation guidance document, technical and scientific input on safety, and quality of HSCT as mentioned in annual report of the WBMN.
In March 2017, Gilead Sciences announced the acquisition of Kite Pharma, which produces products such as Axi-cel to treat non-Hodgkin lymphoma. Plasticell, which specializes in the development of stem cell technologies and cell-based therapies, announced entering into an agreement with Nan yang Technological University (NTU) in Singapore on March 2017, to advance its therapeutic stem cell pipeline. Plasticell also announced collaboration with Anthony Nolan, a research organization in blood cancer, to progress clinical development of Plasticell’s ex vivo expanded cord blood-derived hematopoietic stem cell product in December 2017. Also, GE Healthcare announced the introduction of Thaw CB1000, for thawing large volumes of cell therapies cryopreserved in cryo-bags majorly intended for use in research laboratory, in September 2017.
Important players present in the hematopoietic stem cell transplantation market
Major players operating in the hematopoietic stem cell transplantation market include Pluristem Therapeutics Inc., CellGenix Technologie Transfer GmbH, Kite Pharma Inc., Regen Biopharma Inc., BiolineRx, Cynata Therapeutics, Lonza Group Ltd, Cesca Therapeutics Inc, TiGenix N.V., Escape Therapeutics Inc., Bluebird Bio, and Cellular Dynamics International.
Get More Details On this Report:
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
Visit our news Website: http://www.coherentchronicle.com
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hematopoietic Stem Cell Transplantation (HSCT) Market-Opportunity Analysis, 2017 - 2025 here
News-ID: 966929 • Views: 550
More Releases from Biotechnology
Global Biotechnology Market Report 2019 Companies included Roche, Pfizer, Merck, …
#7th Edition Biotechnology market report recently has been published by market reports company. It features comprehensive market outlook based on historic data from 2013 to 2018 and estimated market trends during the forecast period from 2018 to 2026. To access complete insights of global Biotechnology market report: email@example.com The Biotechnology market delivers a wide array of primary and secondary data with respect to regional and global market. In-depth analysis of numerous
Epigenetics Market by End Users, and by Geography North America, Latin America, …
Increasing research to study the epigenetics of the genome (study called epigenomics) is expected to boost growth of the epigenetics market over the forecast period. Genome-wide epigenetic studies play an important role in the diagnostics of human diseases. Moreover, implementation of epigenetics for oncology research is estimated to propel the growth of epigenetics market. For instance, Constellation Pharmaceuticals, in April 2018, invested US$ 100 million for development of cancer epigenetics
Industrial Microbiology–Solving Big Issues with Micro Size/Microbial Revolutio …
Advances in fields of Recombinant DNA technology, use of microorganisms in treating diseases, rising prevalence of various bacterial, and viral infections globally is expected to boost the growth of industrial microbiology market with respect to pharmaceutical industry. Use of microorganisms in manufacturing various improvised vaccines for existing as well new infectious diseases is supporting the market growth. Cosmetic industry is growing, owing to the factors, such as evolving lifestyles, increasing
Soft Tissue Repair Market, by Product Type Fixation Products, Tissue Patch,
According to the European Union government legislature, European government will be spending almost 80 billion Euros on Research and Development to enhance a broad range of research projects. According to American Joint Replacement Registry (AJRR), around 75% increase in hospitals was reported and 41% increase in the number of surgeons from the year 2012 -2015, hence there is an increment of 102% in the number of cases related to joint
More Releases for Hematopoietic
Hematopoietic Agents Market Estimated to Flourish by 2024
Hematopoiesis is a process of continuous replacement of most mature blood cells. New produced blood cells must be adequate to meet the basic demand of body. Hematopoiesis process needs an ample supply of minerals (e.g., iron, copper, and cobalt) and vitamins (e.g., vitamin B12, folic acid, ascorbic acid, pyridoxine, and riboflavin). Normal hematopoiesis process produces more than 400 billion blood cells each day, this production can be increased several-fold with
Asia-Pacific Hematopoietic Stem Cell Transplantation (HSCT) Market Report 2018
In this report, the Asia-Pacific Hematopoietic Stem Cell Transplantation (HSCT) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. The Values marked with XX is confidential data. To know more about CAGR figures fill in your information so that our business development executive can get in touch with
Important Players Present In The Hematopoietic Stem Cell Transplantation Market
Hematopoietic stem cell transplantation is a procedure in which multipotent hematopoietic stem cells sourced from peripheral blood cells, bone marrow or umbilical cord blood are transplanted into a patient. Hematopoietic stem cell transplantation is commonly used in the treatment of lymphoma (Hodgkin, Non-Hodgkin), leukemia, multiple myeloma, thalassemia, sickle cell anemia, and osteoporosis. It includes two transplantation sources namely, autologous that uses stem cells from the patient’s own body and allogeneic
Hematopoietic Stem Cell Transplantation Global Clinical Trials Review, H2, 2017
"The Report Hematopoietic Stem Cell Transplantation Global Clinical Trials Review, H2, 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Hematopoietic Stem Cell Transplantation Market GlobalData's clinical trial report, Hematopoietic Stem Cell Transplantation Global Clinical Trials Review, H2, 2017" provides an overview of Hematopoietic Stem Cell Transplantation clinical trials scenario. This report provides top line data relating to the clinical trials on
Hematopoietic Stem Cell Transplantation Industry Share Report
Global Hematopoietic Stem Cell Transplantation (HSCT) Market: Snapshot The global market hematopoietic stem cell transplantation (HSCT) has been witnessing a high rise in its valuation and size over the last few years and is anticipated to remain doing so over the next few years. The considerable rise in the geriatric population and the increasing prevalence of non-communicable diseases is the key driving force behind the growth of this market. The increasing
Hematopoietic Stem Cell Transplantation - Pipeline Insight, Market Research Repo …
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “Hematopoietic Stem Cell Transplantation - Pipeline Insight, 2017”. This report provides comprehensive insights of the ongoing therapeutic research and development across Hematopoietic Stem Cell Transplantation. Request For Sample Report@ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1265364 The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of